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Low flow, minimal flow 
and closed circuit system 
inhalational anesthesia in 
modern clinical practice
ABSTRACT
Low, minimal flow and closed circuit anesthesia has been pursued since the beginning of the history of anesthesia. For 
many decades this form of anesthesia has been restricted to devoted enthusiasts and those very fond of gas kinetics. For 
most clinicians, selecting a fresh flow gas higher than 3-5 L/min was widely accepted as a routine anesthesia technique. 
The introduction onto the market of new volatile agents as well as advanced anesthesia machines accompanied by highly 
reliable monitoring systems, made minimal flow or closed system anesthesia feasible on a daily basis. Clinical, cultural, 
environmental, pharmacological, technological and economic reasons, force the modern anesthesiologist to reconsider 
the role of minimal flow and closed circuit volatile anesthesia, in clinical practice.  This paper analyses the main advantages 
offered by these anesthesia techniques. 
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Introduction
Anesthesia circuits are traditionally 
defined as: closed, semi-closed, open 
and semi-open depending on carbon 
dioxide absorber presence, flow and 
inlet position of fresh flow gas (FFG) 
and minute volume ventilation/FFG 
ratio. Rigorously defined taxonomy 
amongst the above mentioned circuits 
is not possible. Furthermore, this clas-
sification does not take into account 
the metabolic demand of each patient, 
strictly related to patient’s body weight, 
age and clinical data.
During volatile anesthesia, two con-
ditions have to be observed: optimal 
narcosis and matching of patient meta-
bolic demand.  These criteria are better 
addressed by a classification such as 
proposed by Baker e Simionescu. This 
classification identifies the anesthesia 
circuit only on FFG basis, and proposes 
the anesthesia continuum concept with 
an overlap among the different FFG 
classes (table 1). (1,2,3)
In spite of Baker and Simionescu’s 
clear and precise classification, many 
anesthesiologists, during everyday clin-
ical practice, usually consider an FFG 
of 2-3 litres as low flow anesthesia.
The majority of anesthesiologists, dur-
ing their clinical practice, usually avoid 
operating with an FFG lower than 1 
l/min due to their cultural and practical 
beliefs including:
- requirement of in depth knowledge on 
gas laws and physics applied to clinical 
anesthesia
- pharmacokinetic and pharmacody-
namic features of halogenated agents 
used until the mid 90’s
- lack of accuracy, expense and limited 
performance of anesthesia machines 
utilized in anesthesia up to the end of 
the 90’s.  (1,2,3)
Cravero reported that in 1994, in the 
United States, 90% of anesthesiologists 
utilized 2-5 l/min of FFG and only 12% 
of physicians used an FFG inferior to 1 
l/min. (4,5)
The recent introduction on the market 
of low solubility halogenated agents 
and the technological development of 
high-performing anesthesia ventilators, 
supplied with feed-back control sys-
tems and high precision monitoring 
systems, make metabolic flow anesthe-
sia safe and feasible on a daily basis. 
This occurrence represents a great 
advantage as far as clinical practice, 
cultural, environmental, pharmacologi-
cal, technological and cost savings 
concerns. 
Clinical evidence
Tracheal intubation bypasses the upper 
airways, thus eliminating the main 
effects on inhaled gases: warming and 
humidification. In the spontaneously 
breathing patient, the isothermic satu-
ration boundary of inspiratory mixture 
(the point where the gases reach 37 
ºC and 100% humidity), is located at 
the 4-5th generation bronchi. After tra-
cheal intubation, as a consequence of 
upper airway bypass, the isothermic 
point is shifted down about 10 cm, in 
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a bronchial region not suited to deal 
with dry and cold gases and not able to 
physiologically condition the respiratory 
mixture. (6,7,8)
As a consequence of these pathophysi-
ological changes, combined with the 
cold and dry medical gases coming 
from the pipeline distribution system, 
two types of consequences occur: 
-  body temperature reduction: caused 
by an increased heat loss from the large 
part of lung tissue exposed to a cold 
and dry breathing mixture. This effect is 
amplified by the peripheral vasodilata-
tion caused by anesthetic agents and 
by muscle paralysis, which prevents 
muscle’s thermogenous function com-
pensation
 - inadequate airway humidification 
and consequent damage of bronchial 
mucosa depends on duration and inten-
sity of humidity alteration. Damages 
occurring in this case involve cilia and 
mucosa gland destruction causing the 
flattening of bronchial pseudostratified 
ciliated columnar epithelium, cellular 
degeneration and increase in desqua-
mation, potentially leading to epithelial 
ulcerations. The reactive hyperemia, a 
consequence of epithelial damages, 
can be considered as an additional 
cause of lung dysfunction.
Volatile anesthesia using minimal or 
metabolic flow circuits can efficaciously 
prevent the above mentioned compli-
cations. According to Kleeman, the 
temperature of the breathing mixture 
can reach 30°C after 1 hour of anesthe-
sia with an FFG of 0,6 l/min, while the 
breathing mixture temperature is not 
subject to any variation if FFG is main-
tained to 1,5 l/min or higher.(8) Finally, a 
rough but explicit sign as far as humidi-
fication is concerned with low flow, is 
the amount of condensed moisture 




According to Ernst’s assertion ...reduc-
ing the FFG to the level of the individual 
uptake, makes the anesthesiologist’s 
working place a physiological labora-
tory at the patient’s head. This state-
ment provides a perfect explanation of 
the cultural role of low, minimal or meta-
bolic flow anesthesia. Working in such 
conditions, forces anesthesiologists to 
improve their clinical and instrumental 
approach to the patient. (9) Particular 
interest has to be paid to achieve in 
depth familiarity and knowledge of the 
following topics:
- variations on time constant of breath-
ing system in relation to fresh gas 
changes (a long one with metabolic 
flow, a shorter one with higher FFG)
- gas kinetics 
- technical features and engineering of 
ventilators. 
A proper combination of the above 
three points combined with the prop-
erties of last generation halogenated 
agents and of their vaporizers technical 
characteristics, consent  fast rise in 
anesthesia depth even without increas-
ing FFG. Opening of a close/low flow 
circuit for a rapid wash-out is absolutely 
required only if a fast recovery from 
anesthesia is considered necessary.
Metabolic flow anesthesia is easily fea-
sible even with traditional ventilators as 
long as a reliable monitoring system 
is available. Both air and N2O must 
be omitted from the breathing mixture 
and only pure O2 has to be used as 
the carrier gas; it follows that pre-oxy-
genation for nitrogen wash out is not 
required and hypoxic respiratory mix-
ture is impossible to be delivered.
Data on gas mixture compounds 
uptake can offer helpful information on 
drug consumption and patient meta-
bolic status, directly influenced by the 
anesthesia depth. 
Anesthesiologist should also be aware 
of metabolic and decay processes of 
volatile anesthetic agents and foreign 
gases accumulation occurring during 
low flow anesthesia. (10) 
Environmental 
concerns
As far as the environment is concerned, 
one of the most important disadvan-
tages of inhaled anesthesia has always 
been pollution both of the workplace, 
i.e. operating rooms, and of the envi-
ronment as a whole. It is evident that, 
using low FFG end re-utilizing the 
compounds of the expired breathing 
mixture, the contamination risk does 
reduce simply as a consequence of the 
reduced total amount of polluting com-
pounds. Therefore, during low flow or 
metabolic anesthesia, even taking into 
account eventual gas leakages from 
the circuits, the amount of total gases 
released in the environment is signifi-
cantly reduced if compared with high 
flow anesthesia. As early as 1979, Virtue 
demonstrated that decreasing the FFG 
from 2,5 l/min to 0,2 l/min, the concen-
tration of N2O at the patient’s head was 
9 times lower. It mustn’t be forgotten 
that using a metabolic system with  O2 
as the sole carrier gas for halogenated 
agents, besides reduction of volumes, 
has the other great advantage of the 
exclusion of  N2O administration. 
Reducing the use of halogenated 
agents, the risk of environmental pollu-
tion will decrease. Halogenated anes-
thetics, in fact, belong to chlorinated 
hydrocarbons, substances which can 
harm the ozone layer. Although the role 
played by volatile anesthetics is trivial 
compared to the damage caused by 
Circuit Fresh gas flow
Metabolic flow ~ 250 ml/min
Minimal flow 250-500 ml/min
Low flow 500-1000 ml/min
Medium flow 1-2 L/min
High flow 2-4 L/min
Open > 4 L/min
Table 1. Classification of anesthesia circuits according to Baker and Simi-
onescu.
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industries and car traffic, social aware-
ness imposes upon us the task to 




As already mentioned, minimal flow 
circuits magnify pharmacokinetic and 
pharmacodynamic properties of last 
generation halogenated agents (des-
flurane and sevoflurane). These drugs 
are characterized by low solubility in 
body tissues together with low anes-
thetic potency. Therefore, their MAC is 
reached with high concentrations in the 
respiratory mixture. High cost, together 
with the greater amount of anesthetic 
required, have long been the major 
obstacle to their use, despite being 
synthesized before the 1970’s. 
Another aspect to be considered is the 
accumulation of volatile foreign sub-
stances inside the circuit during low 
flow anesthesia, in part as a conse-
quence of the metabolism of anesthetic 
agents, and partly as a result of the 
physiological catabolic cascade.
Nitrogen accumulates in the lungs after 
being released by body tissues; this 
occurs markedly in obese patients. The 
main effect of nitrogen accumulation is 
O2 dilution in the breathing mixture.
Methane is usually produced by intes-
tinal bacteria and expelled through the 
lungs. In small amounts, methane can 
be even part of the gases delivered 
by the central gas pipeline, since it is 
present in small percentages in the 
atmosphere. Low flow anesthesia can 
cause the accumulation of this gas just 
because of the trivial wash out of gase-
ous mixture. 
Acetone is another substance derived 
from the body’s metabolism and, since it 
is usually expelled also through airways, 
it can accumulate in the breathing circuit 
when using low FFG. In clinical practice 
this may be particularly important when 
treating cirrhotic patients, those suffer-
ing from diabetes mellitus and patients 
on prolonged starvation. It is advisable 
in such cases not to provide a FFG infe-
rior to 1 l/min, in order to guarantee an 
adequate acetone wash-out.
Carbon monoxide can usually be found 
in the blood of smokers as part of the 
carboxyhemoglobin compound. During 
low flow ventilation the carbon monox-
ide will accumulate in the lungs, both 
deriving from blood wash-out and from 
metabolism of halogenated agents. 
We assume that this plays a major role 
in causing post-operative nausea and 
vomiting.
We should finally mention the com-
pound A generated by using sevoflu-
rane in low flow circuits. Sevoflurane 
molecules in fact demonstrate instability 
at temperatures higher than 38°. During 
exothermic CO2 reaction decay in the 
absorber, if FFG are extremely reduced 
(as in metabolic flow) the refrigerating 
effect on the breathing mixture is inad-
equate, and the temperature will rise 
even over 38°. For this reason it is still 
not advisable to use sevoflurane with an 
FFG lower than 2 l/min. 
Finally, due to the pharmacological 
characteristics of the last inhaling anes-
thetics, together with the advantages 
offered by low flow or metabolic flow 
circuits, volatile anesthesia seems to 
be more advantageous than intrave-
nous anesthesia, especially in regard to 
waking time and awareness prevention. 
(10,11)
Technology 
Technological development does not 
directly involve practitioners. Biomedi-
cal devices should respond to users’ 
friendly requirements so as to be helpful 
during clinical practice, ensuring at the 
same time a high level of quality and 
safety. Physicians must be perfectly 
familiar with the instruments they use at 
work. They even have to be able to rec-
ognize technical limitations and to pro-
pose possible solutions and improve-
ments. Such a role is consistent with not 
only being familiar with technical and 
clinical aspects but also being able to 
prevent legal actions concerning clini-
cal practice.
High technology necessarily includes 
sophisticated control systems, algo-
rithms and auto test procedures to 
verifying the integrity and functionality 
of the machine. The high technology 
checking system is a guarantee not 
only for the clinician but for the patient 
too.
As far as technology is concerned, we 
must mention the Zeus anesthesia work-
station produced by Draeger. It rep-
resents an exclusive machine directly 
descending from Physioflex, another 
Draeger product, which has been the 
first anesthesia machine able to provide 
quantitative inhalatory anesthesia, i.e. 
automatic electronic controlled delivery 
of the exact patient uptake of O2, inhaled 
anesthetic agent and N2O (if utilized).
Zeus workstation gives less informa-
tion, compared to Physioflex (which 
is already out of production), but it is 
characterized by advanced automation 
and a user friendly interface console. It 
is substantially different from all other 
types of anesthesia ventilators, thanks 
to a whirl, placed in its internal circuit of 
4-litre capacity, which is able to origi-
nate a constant flow of approximately 
15 l/min. This feature keeps homogene-
ous and constant the nominal breathing 
mixture composition, and also gen-
erates the driving force necessary to 
ventilate the patient. The halogenated 
agent is not delivered into the circuit 
through a classical vaporizer in line 
with the fresh gas inlet. An injector quite 
similar to those utilized in modern car 
engines, nebulizes the exact amount 
of drug necessary to keep constant the 
preset end expiratory concentration, 
whatever the FFG is. (12,13)
Cost savings
Considering the managing role of phy-
sicians in the modern hospital setting, 
cost savings is one of their major con-
cerns. A very simple example will be 
more explicit than any dissertation in 
economy. Supposing a flow of 2 l/min 
FFG is provided of which 0,5 litres is 
O2 and 1,5 litres is air, and assuming 
average daily anesthesia duration of 
4 hours, 120 litres of O2 and 360 litres 
of air will be consumed. Assuming 200 
anesthesia sessions as the average 
annual activity of a normal operating 
theatre, the total consumption will be 
96,000 litres, of which 24,000 litres is 
O2 and 72,000 litres air. On the con-
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trary, utilizing an FFG of 0,5 L/min, the 
total consumption of medical gases 
will be decreased to 12,000 litres of O2 
(250 ml/min must be guaranteed) and 
12,000 litres of air. If using desflurane 
as the anesthetic agent- and still on a 
yearly projection-6,680 ml will be uti-
lized instead of 26,720 ml, simply by 
reducing FFG from 2 l/min to 0,5 l/min, 
thus saving 4,400 € net in one year 
according to current market prices.
Conclusions
Thanks to current technological and 
pharmacological possibilities, low flow 
anesthesia or closed circuit anesthesia 
are not exclusively performed by a few 
anesthesiologist or “risky fellows” with 
a deep interest in this technique, but 
are now normally utilized in everyday 
clinical practice and it is quite important 
for this type of anesthesia to become a 
common tradition amongst all anesthe-
siologists.
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